Browse the evidence

Gut microbiota dysbiosis in PCOS patients causes insulin resistance and hyperandrogenism through endotoxemia (LPS leakage), altered short-chain fatty acid production, and bile acid metabolism disruption.

For women with PCOS, dietary changes that support gut health (like low-carb, high-fiber diets) may help reduce insulin resistance and hormone imbalances by improving gut barrier function and reducing inflammation. This is not a quick fix but addresses a root cause of the condition.

Elevated plasma branched-chain amino acid (BCAA) levels contribute to the development of insulin resistance through multiple mechanisms, including mTOR/S6K-mediated inhibition of insulin signaling, inhibition of pyruvate dehydrogenase (PDH), and accumulation of toxic metabolites causing mitochondrial dysfunction.

If you have insulin resistance or Type 2 Diabetes, be mindful of very high intakes of branched-chain amino acids (found in red meat, dairy, and supplements), especially when combined with high-fat meals, as this may worsen insulin sensitivity. Focus on balanced protein intake rather than extreme high-protein or high-fat combinations, and prioritize exercise which helps clear BCAA.

Pharmacological activation of the BCKD complex using agents like BT2 or Sodium Phenylbutyrate (NaPB) accelerates BCAA catabolism, lowers plasma BCAA levels, and improves insulin sensitivity in animal models of obesity and diabetes.

Current research shows that drugs like BT2 and NaPB can fix BCAA metabolism issues in lab animals, improving insulin sensitivity. However, these are not yet approved or proven safe for humans for this purpose. Focus on exercise and balanced nutrition to naturally support BCAA clearance.

Different forms of cell death (apoptosis, necroptosis, pyroptosis) in adipose tissue have distinct inflammatory consequences; necroptosis is highly inflammatory and linked to metabolic dysfunction, while apoptosis may trigger anti-inflammatory macrophage responses.

Not all fat loss is created equal. The way fat cells die matters. Necroptosis (inflammatory cell death) worsens metabolic health, while apoptosis might sometimes trigger a less inflammatory response. Strategies that minimize inflammatory cell death may be metabolically superior.

Citrus flavonoids (specifically nobiletin, diosmin, and 8-prenylnaringenin) demonstrate antidiabetic potential in vitro and in vivo by modulating glucose uptake, insulin sensitivity, and lipid metabolism through pathways such as PI3K/Akt, AMPK, and MAPK/ERK.

This paper reviews preclinical evidence that citrus flavonoids (like nobiletin and diosmin) may help manage blood sugar and lipids. However, it explicitly notes these effects have not yet been verified in human studies. Do not use these supplements to replace prescribed diabetes medication without consulting a physician.

GLP-1 receptor agonists may increase the risk of adverse heart failure outcomes in patients with heart failure and reduced left ventricular ejection fraction (LVEF), despite showing cardiovascular benefits in other populations.

If you have heart failure with reduced ejection fraction, GLP-1RAs might increase your risk of heart failure complications. Always inform your doctor about your full heart history before starting these medications.

Activation of AMP-Activated Protein Kinase (AMPK) inhibits white adipose tissue (WAT) development and promotes the differentiation of brown/beige adipose tissue, thereby increasing energy expenditure and reducing obesity.

While you cannot directly 'take' AMPK, the paper identifies it as the central regulator of energy balance. Strategies that activate AMPK (such as exercise, caloric restriction, or specific pharmacological targets mentioned like BMP-8b) can shift the body's fat storage from energy-storing white fat to energy-burning brown/beige fat. This suggests that interventions focusing on metabolic rate and fat quality are more effective than those focusing solely on fat quantity.

Skeletal muscle aging independently increases the risk of insulin resistance through a convergence of mitochondrial dysfunction, intramyocellular lipid accumulation, chronic inflammation, oxidative stress, and sarcopenia.

As you age, your muscles naturally become less efficient at processing glucose due to cellular stress and inflammation. To counter this, prioritize resistance training and aerobic exercise, which directly improve mitochondrial function and reduce inflammation, thereby preserving your insulin sensitivity despite aging.

Mitochondrial dysfunction in aging skeletal muscle, characterized by reduced oxidative capacity and increased ROS production, directly impairs insulin signaling and promotes insulin resistance.

Supporting mitochondrial health through regular physical activity is crucial for maintaining metabolic flexibility and insulin sensitivity as you age.

Intramyocellular lipid (IMCL) accumulation, specifically the buildup of ceramides and diacylglycerol (DAG), impairs insulin signaling by activating inflammatory pathways and interfering with Akt activity.

Managing body fat and lipid metabolism through diet and exercise helps prevent the accumulation of harmful lipids like ceramides in muscles, protecting insulin sensitivity.

Chronic low-grade inflammation (inflammaging) in skeletal muscle, driven by factors like TNF-α and IL-1β, activates IKKβ/NF-κB and JNK pathways, which phosphorylate IRS-1 on serine residues, thereby blocking normal insulin signaling.

Reducing systemic inflammation through anti-inflammatory dietary patterns and exercise can help maintain healthy insulin signaling in muscles.

The anti-seizure effects of ketogenic diets in animal models of epilepsy and autism are mediated by specific gut bacteria (Akkermansia and Parabacteroides) that modulate the GABA/glutamate ratio in the brain.

This mechanism is primarily relevant for understanding the biological basis of KD in neurological disorders. It suggests that the gut microbiome is a key target for therapeutic intervention in epilepsy and autism, potentially allowing for microbiome-based therapies alongside or instead of strict dietary changes.

Thyroid hormone receptor beta (THRβ) agonists and specific thyroid hormone metabolites (T2, T1AM) reduce hepatic lipid content and serum cholesterol in NAFLD and hypercholesterolemia models by stimulating fatty acid oxidation and cholesterol clearance without the cardiac side effects of natural thyroid hormones.

Current standard care for NAFLD focuses on lifestyle changes. However, emerging research indicates that specific thyroid hormone analogs and metabolites (like T2 and T1AM) are being developed to treat liver fat and high cholesterol. These are not yet available as standard treatments but represent a promising future direction for patients who do not respond to lifestyle interventions. Do not self-administer thyroid hormones; consult a specialist about clinical trials if eligible.

Thyroid-stimulating hormone (TSH) directly promotes hepatic lipogenesis and cholesterol biosynthesis, worsening NAFLD and hypercholesterolemia, independent of its role in stimulating thyroid hormone production.

If you have high TSH levels, even if your T3/T4 are normal, it may contribute to fatty liver and high cholesterol. Treating hypothyroidism to normalize TSH might help improve these metabolic markers, although lifestyle changes remain the primary treatment for NAFLD.

Glucagon-Thyroid Hormone (T3) conjugates reduce liver fat and improve dyslipidemia in obesity models by targeting the liver specifically, avoiding the cardiac and skeletal side effects of systemic T3 therapy.

Research is exploring new ways to deliver thyroid hormones to the liver to treat fatty liver disease without affecting the heart or bones. One promising approach involves linking T3 to glucagon to target the liver. This is still experimental and not available as a standard treatment.

High baseline levels of the hepatokine Selenoprotein P (SeP) are associated with 'exercise resistance,' blunting the beneficial metabolic adaptations to exercise and reducing aerobic capacity in obese individuals.

If you are obese and struggling to lose weight despite exercise, high levels of Selenoprotein P might be blunting your results. The paper suggests you may need longer duration or higher intensity exercise to overcome this 'exercise resistance' and improve your body's ability to use fat for fuel.

Beige adipocytes can repress adipose tissue fibrosis and improve glucose homeostasis through mechanisms independent of UCP1 and body weight reduction.

Activating beige fat may improve metabolic health by preventing fat tissue scarring (fibrosis), which helps glucose regulation even without significant weight loss.

Loss-of-function mutations in the zinc transporter SLC30A8 (ZnT8) reduce the risk of type 2 diabetes in humans, likely by preventing the formation of toxic human islet amyloid polypeptide (hIAPP) oligomers through altered insulin oligomerization dynamics.

Do not assume zinc supplementation is a cure-all for diabetes. While deficiency is a risk factor, the paper suggests that genetic variations in zinc transport (ZnT8) significantly impact diabetes risk, and excessive zinc intake may actually worsen metabolic markers. Focus on overall nutrient balance rather than high-dose supplementation without medical guidance.

Chronic activation of AMPK using the direct activator A-769662 promotes white adipose tissue browning, increases energy expenditure, and protects against diet-induced obesity and metabolic dysfunction in high-fat diet-fed mice.

This study suggests that directly activating the AMPK enzyme in fat cells using a specific compound (A-769662) can help burn fat and prevent obesity in mice. While this is not a human supplement, it supports the idea that boosting cellular energy sensors (like AMPK) through exercise or diet might mimic these effects.

Human exposure to endocrine-disrupting compounds (EDCs) found in aquatic environments and drinking water is linked to serious health effects including infertility, thyroid dysfunction, early puberty, endometriosis, diabetes, and obesity.

Be aware that endocrine disruptors like BPA, phthalates, and pesticides are present in water supplies globally. While immediate toxicity is low, long-term accumulation is a concern. Reducing exposure to plastics and processed foods may help minimize intake of these compounds.

Paracetamol use in patients with T2DM and Non-Alcoholic Fatty Liver Disease (NAFLD) carries a heightened risk of hepatotoxicity due to shared metabolic pathways and reduced clearance.

If you have diabetes and take paracetamol regularly for joint pain, ask your doctor to check your liver enzymes. Your liver may process the drug differently if you have fatty liver disease, increasing the risk of damage even at standard doses.

Chronic hyperinsulinemia reduces lifespan and healthspan by suppressing autophagy and antioxidant defenses (Nrf2) while promoting cellular senescence and cardiovascular damage.

To promote longevity, minimize chronic insulin exposure. This supports practices like intermittent fasting, low-carbohydrate diets, and regular exercise, all of which lower baseline insulin. In animal models, lowering insulin extends lifespan; in humans, low insulin levels are associated with healthy aging in nonagenarians.

Myostatin inhibitors (e.g., neutralizing antibodies, soluble receptor decoys) increase muscle mass and strength but are associated with significant side effects, limiting their current utility.

Myostatin inhibitors are investigational drugs that can increase muscle mass and strength but are currently limited by significant side effects like fatigue, confusion, and muscle contractions. They are not yet standard treatments.

Combined oral administration of Scutellariae Radix and Coptidis Rhizoma extracts improves glucose and lipid metabolism in Type 2 Diabetes Mellitus (T2DM) models by downregulating the MAPK inflammatory pathway and upregulating the PI3K/Akt insulin signaling pathway.

This research suggests that a specific combination of Scutellariae Radix and Coptidis Rhizoma extracts may help regulate blood sugar and lipids in T2DM by reducing inflammation and improving insulin signaling. However, this is an animal study; human dosing, safety, and efficacy are not established here. Do not self-medicate with these herbs based on this paper alone.